Adverse Maternal and Fetal Outcome in Cases of Severe Pre-Eclampsia and Eclampsia
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.175 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Tailor Darshit Kantilal und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Hypertensive disorders of pregnancy, particularly severe pre-eclampsia and eclampsia, are major causes of maternal and perinatal morbidity and mortality. These conditions can result in multi-organ dysfunction, HELLP syndrome, renal failure, and placental abruption. Fetal complications include prematurity, low birth weight, and intrauterine growth restriction. Early diagnosis, close monitoring, and timely obstetric intervention are essential to improve maternal and neonatal outcomes.
Aim
To study the maternal and fetal outcomes in cases of severe pre-eclampsia and eclampsia and to identify factors associated with adverse maternal outcomes.
Methods
This hospital-based cross-sectional observational study included 65 pregnant women with severe preeclampsia or eclampsia after 20 weeks of gestation. Sociodemographic, clinical, laboratory, maternal, and perinatal data were collected using a structured proforma. Statistical analysis was performed using descriptive statistics and the chi-square test to assess associations with maternal and fetal outcomes.
Results
Among 65 patients, 48 (73.8%) had severe pre-eclampsia and 17 (26.2%) had eclampsia. Maternal complications occurred in 24 (36.9%), with ICU admission in 14 (21.5%) and maternal mortality in 2 (3.1%). Preterm delivery occurred in 31 (47.7%), low birth weight in 36 (55.4%), and NICU admission in 23 (35.4%). Severe hypertension, thrombocytopenia, multiple severe features, and inadequate antenatal care significantly increased maternal morbidity.
Conclusion
Severe pre-eclampsia and eclampsia are associated with significant maternal and perinatal morbidity. Early detection, regular antenatal monitoring, and timely obstetric intervention are essential to reduce adverse maternal and fetal outcomes.
Zitieren
APA
Kantilal, T. D., Tailor, K., & Malhotra, P. (2026). Adverse Maternal and Fetal Outcome in Cases of Severe Pre-Eclampsia and Eclampsia. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.175
Vancouver
Kantilal TD, Tailor K, Malhotra P. Adverse Maternal and Fetal Outcome in Cases of Severe Pre-Eclampsia and Eclampsia. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.175
BibTeX
@article{Kantilal2026,
author = {Kantilal, Tailor Darshit and Tailor, K.G. and Malhotra, Preeti},
title = {Adverse Maternal and Fetal Outcome in Cases of Severe Pre-Eclampsia and Eclampsia},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.175}
}
EUVIMED